Branded vs. Compounded GLP-1s: A Cost and Regulatory Comparison of Wegovy Access Programs

Levity (搜索)搜索该词条 charges $1,599 per four-week supply of FDA-approved branded Wegovy查看药品详情 (semaglutide查看药品详情 2.4 mg injection), billed approximately every four weeks—around 13 cycles per year—according to pricing captured September 4, 2026. The price includes the FDA-approved medication, online consultation, ongoing care, and shipping, with no separate membership fee. Levity offers a first-month introductory rate of $1,549, after which the standard $1,599 rate applies to every subsequent refill. Over a 52-week year (13 four-week cycles), the effective cost averages approximately $1,728 per calendar month.

In contrast, PlexusDx (搜索)搜索该词条 offers compounded semaglutide查看药品详情 injection at $189 per month month-to-month, or $149 per month on a prepaid six-month plan, using the same all-inclusive model covering consultation, medication, care, and shipping with no membership fee. The key trade-off centers on medication type: Levity (搜索)搜索该词条 dispenses FDA-approved branded Wegovy查看药品详情, while PlexusDx uses compounded semaglutide prepared by licensed 503A pharmacies.

What the $1,599 Levity Price Includes

Levity (搜索)搜索该词条's $1,599 per four-week supply covers four components with no additional line items: FDA-approved branded Wegovy查看药品详情 (semaglutide查看药品详情 2.4 mg pre-filled injection pen) shipped in a four-week supply, an online consultation with a licensed provider to evaluate eligibility and issue the prescription, ongoing care access throughout treatment, and shipping to the patient's address.

There is no separate membership fee, no per-visit charge, and no dosing surcharge. The same $1,599 rate applies whether a patient is on a lower titration dose or the full maintenance dose. Levity (搜索)搜索该词条's cancel-anytime policy means patients are not locked into a multi-month commitment, though each billing cycle is approximately four weeks, so over a 52-week year a continuously enrolled patient will be charged roughly 13 times.

Normalized 12-Month Cost Comparison

Because Levity (搜索)搜索该词条 bills every four weeks while most competing programs bill monthly, direct comparison requires normalizing to a 52-week year. Over one year of continuous treatment, Levity's branded Wegovy查看药品详情 costs approximately $18,469 more than PlexusDx (搜索)搜索该词条 month-to-month compounded semaglutide查看药品详情, and $18,949 more than the PlexusDx six-month prepaid option. Both programs include consultation, medication, care, and shipping in their advertised rates, and neither charges a membership fee.

The 52-week Levity (搜索)搜索该词条 total is approximately $20,737, assuming one cycle at the first-month rate and twelve refills at $1,599.

The Regulatory Distinction: Branded vs. Compounded

The price gap reflects a fundamental difference in medication type. Levity (搜索)搜索该词条 dispenses FDA-approved branded Wegovy查看药品详情, manufactured by Novo Nordisk查看公司主页 under New Drug Application (NDA) review. The FDA has evaluated Wegovy's safety, effectiveness, manufacturing quality, and labeling.

PlexusDx (搜索)搜索该词条 dispenses compounded semaglutide查看药品详情 prepared by licensed 503A compounding pharmacies. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Both deliver the same active pharmaceutical ingredient—semaglutide查看药品详情—at the same target maintenance dose of 2.4 mg weekly for weight management. Compounding became widespread when branded GLP-1 drugs were in shortage and remains an option now that shortages have eased. Patients who place high value on FDA approval of the finished drug product, or whose insurance covers branded Wegovy查看药品详情, may prefer Levity (搜索)搜索该词条's offering despite the cost premium. Patients paying out-of-pocket and comfortable with compounded medication can achieve equivalent dosing at a fraction of the annual spend.

Other Levity Branded Options

Levity (搜索)搜索该词条 also offers two additional FDA-approved GLP-1 products, both billed every four weeks. Ozempic查看药品详情 (branded semaglutide查看药品详情 injection, FDA-approved for type 2 diabetes (搜索)搜索该疾病) is priced at $1,149 for the first month, then $1,199 per four-week refill. Mounjaro查看药品详情 (branded tirzepatide查看药品详情 injection, FDA-approved for type 2 diabetes) is priced at $1,249 for the first month, then $1,299 per four-week refill.

Both are priced below Wegovy查看药品详情 but still carry substantial premiums over compounded alternatives. Ozempic查看药品详情 and Mounjaro查看药品详情 are FDA-approved for diabetes management, not weight loss, though clinicians may prescribe them off-label for weight management when clinically appropriate.

Strengths and Transparency Gaps

Levity (搜索)搜索该词条's strengths include regulatory clarity through FDA-approved branded medication with full NDA review and manufacturing oversight, transparent bundled pricing with no hidden fees or separate membership, a cancel-anytime policy with no multi-month contract, and a straightforward website where pricing and inclusions are clearly stated.

Considerations include a high absolute cost—at roughly $1,728 per calendar month, Levity (搜索)搜索该词条 is accessible primarily to patients with insurance coverage or high discretionary income. The four-week billing cycle means approximately 13 charges per year, which can create budgeting complexity compared to fixed monthly billing. Levity's website does not specify whether it provides documentation for insurance reimbursement or works with FSA/HSA accounts, and offers less detail on titration protocols, monitoring cadence, or clinical support structure compared to some competitors. No verified review data was captured in this research cycle, so patient satisfaction and service quality remain unverified.

PlexusDx (搜索)搜索该词条 holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026).